SARS-CoV-2 infection in a pediatrics STAT1 GOF patient under Ruxolitinib therapy-a matter of balance?
Paloma Guisado Hernández, Pilar Blanco-Lobo, Isabel Villaoslada, Beatriz de Felipe, José Manuel Lucena, Guillermo Martín-Gutiérrez, María José Castro, Alicia Gutiérrez‐Valencia, María Isabel Sánchez Códez, Mirella Gáboli, Olaf Neth, Peter Olbrich
Topics & Concepts
Medical microbiologyMedicineRuxolitinibSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Virology2019-20 coronavirus outbreakPediatricsBalance (ability)Intensive care medicineInternal medicinePhysical therapyDiseaseInfectious disease (medical specialty)OutbreakBone marrowMyelofibrosisAutoimmune and Inflammatory Disorders ResearchMyeloproliferative Neoplasms: Diagnosis and TreatmentCOVID-19 Clinical Research Studies